Literature DB >> 10540161

Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis.

P D Hodgson1, M D Grant, T I Michalak.   

Abstract

The Fas ligand (FasL)/Fas and the perforin-granzyme cytotoxic pathways presumably play a central role in the development of hepatocellular injury in viral hepatitis. To recognize the potential contribution of FasL and perforin-based cell killing in hepadnaviral infection, we adopted a cytotoxic assay using murine Fas+ P815 and human Fas- K562 cells as targets. Freshly isolated peripheral blood mononuclear cells (PBMC) from woodchucks with newly acquired woodchuck hepatitis virus (WHV) infection (n = 6), with chronic WHV hepatitis (n = 9), and from healthy animals (n = 11) were used as effector cells. We have found that woodchuck lymphoid cells kill cell targets via both the FasL/Fas and the perforin death pathways. The contribution of Fas-dependent cytolysis was ascertained in blocking experiments with anti-Fas antibody and by incubation of PBMC with cyclohexamide to prevent de novo synthesis of FasL. The involvement of the perforin pathway was confirmed by treatment of K562 cells with colchicine to inhibit the microtubule-dependent perforin release. Comparative analysis showed that peripheral lymphoid cells from acute WHV hepatitis, but not those from chronic WHV infection, are more cytotoxic and that this increase seems to be entirely due to activation of perforin-mediated killing. The data indicate that acute infection in woodchucks is associated with the augmented capacity of lymphoid cells to elicit perforin-dependent killing, but in chronic infection, independent of the severity of liver disease and duration of chronicity, these cells have the same or lower cytotoxic potential as PBMC from healthy controls. These findings suggest a role for non-specific cellular immunity, presumably natural killer (NK) cells, in the control of early WHV infection and in the progression of chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540161      PMCID: PMC1905398          DOI: 10.1046/j.1365-2249.1999.01010.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

Review 1.  The role of natural killer cells in viral infections.

Authors:  D M See; P Khemka; L Sahl; T Bui; J G Tilles
Journal:  Scand J Immunol       Date:  1997-09       Impact factor: 3.487

2.  Natural killing activities in chronic liver diseases and hepatocellular carcinoma.

Authors:  K Ono; Y Yamanaga; K Yamamoto; S I Koga; J Nishimura; H Nawata
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice.

Authors:  Y Nakamoto; L G Guidotti; V Pasquetto; R D Schreiber; F V Chisari
Journal:  J Immunol       Date:  1997-06-15       Impact factor: 5.422

Review 4.  Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells.

Authors:  R R Brutkiewicz; R M Welsh
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

5.  Essential roles of the Fas ligand in the development of hepatitis.

Authors:  T Kondo; T Suda; H Fukuyama; M Adachi; S Nagata
Journal:  Nat Med       Date:  1997-04       Impact factor: 53.440

6.  Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways.

Authors:  M J Smyth; V R Sutton; M H Kershaw; J A Trapani
Journal:  Transplantation       Date:  1996-11-27       Impact factor: 4.939

Review 7.  The relative role of lymphocyte granule exocytosis versus death receptor-mediated cytotoxicity in viral pathophysiology.

Authors:  M J Smyth; J A Trapani
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Human Fas ligand: gene structure, chromosomal location and species specificity.

Authors:  T Takahashi; M Tanaka; J Inazawa; T Abe; T Suda; S Nagata
Journal:  Int Immunol       Date:  1994-10       Impact factor: 4.823

9.  Detection of hepatitis B and woodchuck hepatitis viral DNA in plasma and mononuclear cells from heparinized blood by the polymerase chain reaction.

Authors:  I U Pardoe; T I Michalak
Journal:  J Virol Methods       Date:  1995-02       Impact factor: 2.014

10.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.

Authors:  B Rehermann; P Fowler; J Sidney; J Person; A Redeker; M Brown; B Moss; A Sette; F V Chisari
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  10 in total

Review 1.  The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection.

Authors:  Stephan Menne; Paul J Cote
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 2.  The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.

Authors:  Michael Roggendorf; Anna D Kosinska; Jia Liu; Mengji Lu
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-28       Impact factor: 6.915

3.  Posttranscriptional inhibition of class I major histocompatibility complex presentation on hepatocytes and lymphoid cells in chronic woodchuck hepatitis virus infection.

Authors:  T I Michalak; P D Hodgson; N D Churchill
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Correlation of virus and host response markers with circulating immune complexes during acute and chronic woodchuck hepatitis virus infection.

Authors:  Dieter Glebe; Heike Lorenz; Wolfram H Gerlich; Scott D Butler; Ilia A Tochkov; Bud C Tennant; Paul Cote; Stephan Menne
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

5.  Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.

Authors:  Clifford S Guy; Patricia M Mulrooney-Cousins; Norma D Churchill; Tomasz I Michalak
Journal:  J Virol       Date:  2008-07-02       Impact factor: 5.103

Review 6.  Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.

Authors:  Mark A Feitelson; Helena M G P V Reis; N Lale Tufan; Bill Sun; Jingbo Pan; Zhaorui Lian
Journal:  Cancer Lett       Date:  2009-02-06       Impact factor: 8.679

7.  Effector role of neonatal hepatic CD8+ lymphocytes in epithelial injury and autoimmunity in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Gregg Sabla; Sujit Mohanty; Monica McNeal; Richard Ward; Keith Stringer; Charles Caldwell; Claire Chougnet; Jorge A Bezerra
Journal:  Gastroenterology       Date:  2007-04-20       Impact factor: 22.682

Review 8.  T-cells in human encephalitis.

Authors:  Christian G Bien; Jan Bauer
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

9.  Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.

Authors:  Ali Sakhdari; Shariq Mujib; Bahareh Vali; Feng Yun Yue; Sonya MacParland; Kiera Clayton; Richard Bradley Jones; Jun Liu; Erika Yue Lee; Erika Benko; Colin Kovacs; Jennifer Gommerman; Rupert Kaul; Mario A Ostrowski
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

10.  Pit cells exclusively kill P815 tumor cells by the perforin/granzyme pathway.

Authors:  David Vermijlen; Dianzhong Luo; Christopher J Froelich; Jan P Medema; Jean A Kummer; Erik Willems; Filip Braet; Eddie Wisse
Journal:  Comp Hepatol       Date:  2004-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.